These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Olifen action on mutagenesis in human lymphocytes]. Mazurov VI; Filev LV; Sinopal'nikov DO; Enokhin SF; Petrova TN; Medvedev IV; Volchek IV; Bykhovets IV Klin Med (Mosk); 1996; 74(9):58-61. PubMed ID: 9121094 [TBL] [Abstract][Full Text] [Related]
30. [Use of antioxidants and lidase in pulmonary tuberculosis]. Gur'eva IG; Andrzheiuk NI; Starostenko EV; Smirnova NA; Elistratova NA Probl Tuberk; 1988; (1):52-6. PubMed ID: 3362823 [No Abstract] [Full Text] [Related]
31. [Efficiency treatment of new cases of destructive pulmonary tuberculosis in the presence of concurrent iron deficiency anemia]. Voloshina VV; Fomicheva NI Probl Tuberk; 2002; (2):10-2. PubMed ID: 11899794 [TBL] [Abstract][Full Text] [Related]
32. [Antioxidant effectiveness in preventing and eliminating the side effects of antibacterial preparations in pulmonary tuberculosis patients]. Starostenko EV; Andrzheiuk NI; Salpagarov AM Probl Tuberk; 1987; (10):34-7. PubMed ID: 3422950 [No Abstract] [Full Text] [Related]
33. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis]. Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825 [TBL] [Abstract][Full Text] [Related]
34. [Adverse effects of multi-drug therapy in patients with tuberculosis and ways of their correction]. Gel'berg IS; Vol'f SB; Vrublevskaia NI; Pigalkova EN; Krotkova EN; Shevchuk DV; Avlasenko VS Probl Tuberk; 2002; (4):12-6. PubMed ID: 12125243 [TBL] [Abstract][Full Text] [Related]
35. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis]. Khomenko AG; Chukanov VI; Korneev AA Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768 [TBL] [Abstract][Full Text] [Related]
36. [The effectiveness of ascorbic acid and emoxipin in treatment of infiltrative pulmonary tuberculosis]. Volchegorskiĭ IA; Novoselov PN; Astakhova TV Klin Med (Mosk); 2007; 85(12):55-8. PubMed ID: 18318169 [TBL] [Abstract][Full Text] [Related]
37. [The combined treatment with aurobin and dipromonium of focal scleroderma]. Khamaganova IV Vestn Dermatol Venerol; 1989; (9):66-9. PubMed ID: 2609771 [TBL] [Abstract][Full Text] [Related]
38. [Use of essentiale in chronic liver diseases in patients with pulmonary tuberculosis]. Blikhar EM; Skakun NP Probl Tuberk; 1988; (3):41-4. PubMed ID: 3387393 [No Abstract] [Full Text] [Related]
39. [Studies on steroid hormone stimulation therapy for chronic lung tuberculosis]. Adachi M Kekkaku; 1968 Jan; 43(1):35-46. PubMed ID: 4299626 [No Abstract] [Full Text] [Related]
40. [Characteristics of newly detected destructive forms of pulmonary tuberculosis]. Litvin LM; Rybak IuN; Ladnyĭ AIa; Nemesh AA; Sirko AV Vrach Delo; 1981 May; (5):25-6. PubMed ID: 7257255 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]